当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析 - 资产负债表

康辰药业

(603590)

  

流通市值:47.64亿  总市值:48.29亿
流通股本:1.57亿   总股本:1.59亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金212,131,620.11189,977,701.84307,759,615.46277,333,490.87
应收票据及应收账款302,722,762.67251,013,321.48289,160,633.42272,585,350.22
应收账款302,722,762.67251,013,321.48289,160,633.42272,585,350.22
应收款项融资4,328,518.66,363,2885,720,828.486,074,887.1
预付款项9,745,892.94,712,451.0228,771,043.4430,815,082.89
其他应收款合计33,796,59833,841,304.8634,391,717.7236,557,908.86
存货69,870,047.2172,383,172.3460,894,611.2372,225,109.11
其他流动资产168,930,402.2577,586,421.5875,360,368.2733,674,825.68
流动资产平衡项目0000
流动资产合计1,192,375,175.061,086,540,037.051,134,614,428.361,111,299,616.69
非流动资产:
长期股权投资49,141,244.0849,322,264.2949,170,120.5748,362,500.17
其他权益工具投资703,359,892.89748,399,124.49740,514,803.77703,526,733.13
其他非流动金融资产88,083,749.0188,804,516.5574,323,50774,259,985.86
固定资产193,589,225.97199,173,514.04205,001,305.39207,846,396.82
在建工程217,857,179.85209,845,880.18209,105,161.76208,024,247.13
生产性生物资产400,000437,500--
使用权资产15,531,822.7817,275,950.9419,020,079.095,294,116.78
无形资产840,040,613.57842,667,929.51848,022,890.3850,317,584.8
开发支出248,557,598.83233,770,135.29194,885,624.65178,276,162.61
商誉--97,642,801.597,642,801.5
长期待摊费用547,669.74587,961.17640,877.59693,794.02
递延所得税资产24,766,826.4927,465,038.7421,043,408.3323,435,591.32
其他非流动资产310,917,356.75415,399,038.2402,071,309.8399,514,173.9
非流动资产平衡项目0000
非流动资产合计2,692,793,179.962,833,148,853.42,861,441,889.752,797,194,088.04
资产平衡项目0000
资产总计3,885,168,355.023,919,688,890.453,996,056,318.113,908,493,704.73
流动负债:
短期借款159,739,719.5140,955,196.27103,045,986.779,063,508.11
应付票据及应付账款51,283,103.8773,569,212.7598,437,923.84107,089,090.7
应付账款51,283,103.8773,569,212.7598,437,923.84107,089,090.7
合同负债3,325,933.916,426,596.762,191,802.843,396,120.49
应付职工薪酬20,939,151.5343,685,764.123,740,119.5420,816,078.17
应交税费7,124,639.318,880,929.217,755,065.873,255,561.62
其他应付款合计62,192,968.4371,082,843.4468,089,436.42132,175,891.04
应付股利---47,694,413.1
一年内到期的非流动负债8,138,084.098,071,679.0916,185,194.978,932,699.74
其他流动负债21,561.1710,993.6425,339.8615,105.69
流动负债平衡项目0000
流动负债合计312,765,161.81352,683,215.26319,470,870.04354,744,055.56
非流动负债:
长期借款49,576,40949,845,80985,451,50664,102,306
租赁负债8,980,667.3410,800,404.4212,551,921.23,835,961.18
递延收益39,549,246.5140,475,455.1420,706,963.7621,633,172.38
递延所得税负债34,632,686.7539,720,009.8740,461,525.1432,773,855.17
非流动负债平衡项目0000
非流动负债合计132,739,009.6140,841,678.43159,171,916.1122,345,294.73
负债平衡项目0000
负债合计445,504,171.41493,524,893.69478,642,786.14477,089,350.29
所有者权益(或股东权益):
实收资本(或股本)159,356,477159,356,477160,000,000160,000,000
资本公积948,240,986.8944,595,003.46959,952,197.71965,567,318.52
减:库存股35,927,57035,927,57055,923,616.5378,590,519.53
其他综合收益-6,488,332.1331,795,014.7325,093,342.11-7,621,517.93
盈余公积80,000,00080,000,00080,000,00080,000,000
未分配利润2,009,090,794.281,964,593,400.482,035,305,885.972,001,533,050.08
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,154,272,355.953,144,412,325.673,204,427,809.263,120,888,331.14
少数股东权益285,391,827.66281,751,671.09312,985,722.71310,516,023.3
股东权益平衡项目0000
股东权益合计3,439,664,183.613,426,163,996.763,517,413,531.973,431,404,354.44
负债和股东权益合计3,885,168,355.023,919,688,890.453,996,056,318.113,908,493,704.73
公告日期2025-04-262025-04-262024-10-302024-08-28
审计意见(境内)标准无保留意见
TOP↑